GlassScriptPhysician profile
Asad U Khan
NPI 1134233372
$5,399.28
in general payments reported to CMS, 2019-2025
32 companies · $478 in 2025
The $478 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $218 · 2021: $662 · 2022: $1,091 · 2023: $1,587 · 2024: $1,008 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,073.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $905.16 | 2019-2025 | Breztri, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $849.00 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Harmony Biosciences LLC | $655.35 | 2021-2025 | Wakix |
| Genzyme Corporation | $362.25 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $354.67 | 2021-2025 | |
| Insmed, INC. | $244.12 | 2019-2024 | Arikayce |
| Mylan Specialty L.P. | $230.69 | 2019-2024 | Yupelri |
| Biosense Webster, INC. | $182.37 | 2025 | Carto 3 |
| Abbvie INC. | $167.48 | 2021-2023 | |
| Amgen INC. | $141.60 | 2022-2025 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.06 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $136.89 | 2019-2024 | Dupixent |
| Philips North America LLC | $133.86 | 2019-2025 | Vest Therapy Und |
| Tactile Systems Technology INC | $109.08 | 2024 | Entre Plus, Flexitouch Plus |
| Takeda Pharmaceuticals U.S.A., INC. | $106.75 | 2021-2023 | Aralast, Cuvitru |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $98.74 | 2023-2024 | Sunosi |
| Grifols USA, LLC | $97.69 | 2020-2025 | Prolastin-C Liquid |
| Olympus America INC. | $58.07 | 2024 | Spiration Valve System |
| Pfizer INC. | $53.81 | 2020-2022 | |
| Allergan, INC. | $52.99 | 2020 | |
| Inogen, INC. | $44.04 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Avanos Medical | $38.80 | 2021 | |
| Inspire Medical Systems, INC. | $37.03 | 2023-2024 | Inspire |
| Merck Sharp & Dohme LLC | $36.41 | 2023-2024 | Zerbaxa |
| Bayer Healthcare Pharmaceuticals INC. | $34.72 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $23.52 | 2024 | Lumryz |
| Viatris Specialty LLC | $21.84 | 2025 | Yupelri |
| Ani Pharmaceuticals, INC. | $21.71 | 2024 | Purified Cortrophin Gel |
| Vifor Pharma, INC. | $20.42 | 2024 | Veltassa |
| Advanced Respiratory, INC | $15.60 | 2020 | |
| Genentech USA, INC. | $13.65 | 2023 | Xolair |
| Mallinckrodt Enterprises LLC | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.